CClinicalTrials.gg
Status unknownNCT03875222Updated Mar 19, 2019

New Criteria for Accessory Pathway Localization From Surface ECG

An observational study in Accessory Pathway, sponsored by Assiut University. Status unknown. Open to participants aged 10 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-03-19.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Mar 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
10 Years to 90 Years
Sex
All
01

Study summary

study for discovering new criteria for localization of site of accessory pathway from surface ECG

Read the detailed description

the study aims for discovering new criteria for percise localization of accessory pathway from surface ECG in referance to final flouroscopic ablation site

02

Conditions studied

  • Accessory Pathway
03

In context

Lead sponsor

Assiut University is the lead sponsor of 4,916 studies on the registry; 2,113 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 90 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

any patient with manifest accessory pathway between 10 and 90 years of age undergoing EP maping and ablation.

Inclusion criteria

  • any patient with manifest accessory pathway .

Exclusion criteria

Exclusion Criteria:

  • multiple accessory pathways .previous ablation.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. percise localization of accessory pathway from surface ECG in referance to successful ablation site

    successful localization of accessory pathway from surface ECG in referance to successful ablation site during EP maping

    Time frame: 2 years

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03875222
Lead sponsor
Assiut University
Responsible party
Haidy Yacoup Daoud Danial (principle investigator, Assiut University) — Principal investigator
First posted
Mar 14, 2019
Start date
Apr 2019 (estimated)
Primary completion
Apr 2021 (estimated)
Completion
Aug 2021 (estimated)
Last update
Mar 19, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion